Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
9
Norwegian register · Mar 2026
Grants
$2.7M
1 grant · CORDIS
Backers
1
Norselab
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 1, 2024 Won a grant $2.7M · CORDIS Sep 17, 2020 Founded per the company register
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Grant Jun 2024 $2.7M — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity DOMORE DIAGNOSTICS AS brreg.no
Registered 17 Sep 2020
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
iLof51-200 employees • 4 roles
Optomics® uses photonics and AI to decode human biology for clinical diagnostics, trial stratification, and drug development. Personalized…
FidoCureFounded 2018
AI-Enabled Personalized Therapeutics for Canine Cancer. Personalized therapeutics can offer a more hopeful prognosis. FidoCure®, developed…
AignosticsSeries B $34M · 22 mo ago • Founded 2018 • 51-200 employees • 1 role
Aignostics is a Berlin company founded in 2018 as a spin-out from the Charité hospital and its artificial intelligence institute. Its…
PortraiFounded 2021
Founded in 2021 by four Seoul National University medical researchers, Portrai fuses spatial biology and AI to make drug development…
GenomateConvertible Note $2M · 18 mo ago • Founded 2022 • 51-200 employees
Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their…
Universal DXSeries B $70M · 2 yr ago • Founded 2012 • 51-200 employees • 6 roles
We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and…

Overview

DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective.

People

Tomas Nordheim Alme
Chair of the board
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Oslo Norway
HQ
10-50 est. staff

Financials

Total raised
$2.7M
Latest round
Grant
Funding rounds
1
Funding rounds
Round Announced Amount
Grant 2024 $2.7M Details